EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients

Miloš Marković, Nataša Petronijević iD, Milena Stašević, Ivana Stašević Karličić, Milica Velimirović, Tihomir Stojković, Slavica Ristić iD, Mina Stojković iD, Nataša Milić, Tatjana Nikolić iD

Cells · 11.12.2023 · 12 (24) · 2814

DOI: 10.3390/cells12242814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 11.12.2023. Verfasst von Miloš Marković und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Mental Disorders "Dr Laza Lazarević", 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Antipsychotic Agents, Schizophrenia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tryptophan (TRP) catabolites exert neuroactive effects, with the plethora of evidence suggesting that kynurenic acid (KYNA), a catabolite of the kynurenine pathway (KP), acts as the regulator of glutamate and acetylcholine in the brain, contributing to the schizophrenia pathophysiology. Newer evidence regarding measures of KP metabolites in the blood of schizophrenia patients and from the central nervous system suggest that blood levels of these metabolites by no means could reflect pathological changes of TRP degradation in the brain. The aim of this study was to investigate plasma concentrations of TRP, kynurenine (KYN) and KYNA at the acute phase and remission of schizophrenia in a prospective, case-control study of highly selected and matched schizophrenia patients and healthy individuals. Our study revealed significantly decreased KYN and KYNA in schizophrenia patients (p < 0.001), irrespective of illness state, type of antipsychotic treatment, number of episodes or illness duration and no differences in the KYN/TRP ratio between schizophrenia patients and healthy individuals. These findings could be interpreted as indices that kynurenine pathway might not be dysregulated in the periphery and that other factors contribute to observed disturbances in concentrations, but as our study had certain limitations, we cannot draw definite conclusions. Further studies, especially those exploring other body compartments that participate in kynurenine pathway, are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsSchizophreniaHumansKynurenineKynurenic AcidCase-Control StudiesProspective StudiesTryptophan

Stichwörter der Autor:innen

bloodfirst-episodekynurenic acidkynurenineplasmaschizophreniatryptophan

Substanzen

KynurenineKynurenic AcidAntipsychotic AgentsTryptophan

Autor:innen und Institutionen

  • Clinic for Mental Disorders "Dr Laza Lazarević", 11000 Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Faculty of Medicine, University of Priština-Kosovska Mitrovica, 38220 Kosovska Mitrovica, Serbia.
  • Clinic for Neurology, University Clinical Centre of Niš, 18000 Niš, Serbia.
  • Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

ORCID-Profile: Nataša Petronijević, Slavica Ristić, Mina Stojković, Tatjana Nikolić

Zitieren

APA

Marković, M., Petronijević, N., Stašević, M., Stašević Karličić, I., Velimirović, M., Stojković, T., Ristić, S., Stojković, M., Milić, N., & Nikolić, T. (2023). Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients. Cells, 12(24), 2814. https://doi.org/10.3390/cells12242814

Vancouver

Marković M, Petronijević N, Stašević M, Stašević Karličić I, Velimirović M, Stojković T, et al. Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients. Cells. 2023;12(24):2814. doi:10.3390/cells12242814

BibTeX
@article{Markovi2023,
  author = {Marković, Miloš and Petronijević, Nataša and Stašević, Milena and Stašević Karličić, Ivana and Velimirović, Milica and Stojković, Tihomir and Ristić, Slavica and Stojković, Mina and Milić, Nataša and Nikolić, Tatjana},
  title = {Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {24},
  pages = {2814},
  doi = {10.3390/cells12242814}
}
Kostenlos starten →